CTS vs PODD · P/E 22, rev $541.3M vs P/E 34, rev $2.07B
CTS Corporation (CTS) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
CTS Corporation (CTS) is a electronic components company listed on US.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CTS revenue for 2025-12-31 was $541.3M. Net income was $65.3M. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. CTS currently screens at market cap $1.30B and trailing P/E 22.1.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CTS currently screens at market cap $1.30B and trailing P/E 22.1. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CTS and PODD stock pages for the full models.
Not investment advice.